B. Metzler Seel. Sohn & Co. Holding Ag Bio Rad Laboratories, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 1,262 shares of BIO stock, worth $449,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,262
Previous 1,318
4.25%
Holding current value
$449,234
Previous $983,000
42854.22%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BIO
# of Institutions
451Shares Held
17.7MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$679 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$552 Million0.01% of portfolio
-
Veritas Asset Management LLP1.09MShares$387 Million3.03% of portfolio
-
Van Eck Associates Corp723KShares$258 Million0.3% of portfolio
-
First Eagle Investment Management, LLC713KShares$254 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.77B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...